BIT
LUMO

BlackRock Institutional Trust’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

BlackRock Institutional Trust’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.57M Buy
60,164
+1,635
+3% +$184K ﹤0.01% 2686
2016
Q3 		$7.91M Buy
58,529
+1,089
+2% +$108K ﹤0.01% 2481
2016
Q2 		$5.82M Sell
57,440
-340
-0.6% -$42.1K ﹤0.01% 2601
2016
Q1 		$9.46M Sell
57,780
-272
-0.5% -$55.1K ﹤0.01% 2289
2015
Q4 		$19M Buy
58,052
+3,807
+7% +$1.24M ﹤0.01% 1901
2015
Q3 		$17.5M Buy
54,245
+2,669
+5% +$1.17M ﹤0.01% 1928
2015
Q2 		$20.6M Sell
51,576
-1,921
-4% -$816K ﹤0.01% 1906
2015
Q1 		$26.3M Buy
53,497
+12,227
+30% +$4.74M ﹤0.01% 1761
2014
Q4 		$14.8M Buy
41,270
+17,621
+75% +$5.24M ﹤0.01% 2105
2014
Q3 		$4.56M Sell
23,649
-1,860
-7% -$409K ﹤0.01% 2732
2014
Q2 		$6.09M Buy
25,509
+1,262
+5% +$257K ﹤0.01% 2690
2014
Q1 		$6.2M Buy
24,247
+1,848
+8% +$565K ﹤0.01% 2691
2013
Q4 		$4.44M Sell
22,399
-1,215
-5% -$216K ﹤0.01% 2845
2013
Q3 		$3.99M Buy
23,614
+642
+3% +$103K ﹤0.01% 2828
2013
Q2 		$4.08M Buy
+22,972
New +$3.25M ﹤0.01% 2795

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

BlackRock Institutional Trust's LUMO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 2.8% in Q4 2016, buying an estimated $184K and bringing the position to 60,164 shares worth $5.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2686.

BlackRock Institutional Trust first reported a position in LUMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $26.3M in Q1 2015. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

  • BlackRock Institutional Trust held 60,164 shares of Lumos Pharma, Inc. Common Stock worth $5.57M as of Q4 2016.
  • BlackRock Institutional Trust bought 1,635 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $184K.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2686 holding.
  • BlackRock Institutional Trust first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Lumos Pharma, Inc. Common Stock position peaked at $26.3M in Q1 2015.
  • 122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.